POSB13 Thirty-Day Readmission in US Hospitalized COVID-19 Patients

por Mozaffari, E, Liang, S, Stewart, HM, Thrun, M, Hodgkins, P, Haubrich, R
Publicado 2022

PIN82 Real-World Utilization of Remdesivir in 2020: A Retrospective Cohort Study

por Mozaffari, E., Chandak, A., Liang, S., Gayle, J., Haubrich, R., Thrun, M., Hodgkins, P.
Publicado 2021

Are hospitals delivering appropriate VTE prevention? The venous thromboembolism study to assess the rate of thromboprophylaxis (VTE start)

por Amin, A., Spyropoulos, A. C., Dobesh, P., Shorr, A., Hussein, M., Mozaffari, E., Benner, J. S.
Publicado 2009

POSB12 Association Between Remdesivir Treatment and In-Hospital All-Cause Mortality Among Patients Hospitalized with COVID-19

por Mozaffari, E, Zhang, Z, Thrun, M, Gottlieb, RL, Kuritzkes, DR, Sax, PE, Wohl, D, Casciano, R, Hodgkins, P, Haubrich, R, Chandak, A
Publicado 2022